Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and
the third most common cause of cancer mortality1. Despite the high numbers of
patients diagnosed worldwide (the estimated number of people is 0.5 million cases
per year), HCC continue to pose challenging clinical problems. The assessment of
the tumor and treatment options needs a multi-disciplinary approach in
Publication date
13/02/2008
Field of study
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and
the third most common cause of cancer mortality1. Despite the high numbers of
patients diagnosed worldwide (the estimated number of people is 0.5 million cases
per year), HCC continue to pose challenging clinical problems. The assessment of
the tumor and treatment options needs a multi-disciplinary approach i